Skip to main content
. 2012 Sep 26;1(2):e7. doi: 10.2196/ijmr.2101

Table 2.

Frequency of over-the-counter medication use in respondents with and without proton pump inhibitor (PPI) use.

Frequency
(days/week)
No PPI use PPI use
No GERDa
(n = 37,950)
Low-impact
GERD
(n = 34,444)
High-impact
GERD
(n = 32,935)
Adequate
relief
(n = 3131)
Partial
responseb
(n = 22,826)
<1 31,673 (83.46%) 21,215 (61.59%) 2846 (8.64%) 2221 (70.94%) 8352 (36.59%)
1 4086 (10.77%) 9128 (26.50%) 3169 (9.62%) 910 (29.06%) 2195 (9.62%)
2–3 1692 (4.46%) 4101 (11.91%) 13,427 (40.77%) 0 (0%) 4587 (20.10%)
4–7 499 (1.31%) 0 (0%) 13,493 (40.97%) 0 (0%) 7692 (33.70%)

a Gastroesophageal reflux disease.

b Partial response: heartburn, regurgitation, sleep disturbance, or over-the-counter medication use for >1 day during the preceding week.